Healthcare provider profile · identity verified

Mark Edward Vig, MD

Internal Medicine · TYLER, TX · NPI 1023251527

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	805	227
Amlodipine Besylate	Amlodipine Besylate	746	217
Levothyroxine Sodium	Levothyroxine Sodium	516	132
Losartan Potassium	Losartan Potassium	461	140
Rosuvastatin Calcium	Rosuvastatin Calcium	432	137
Gabapentin	Gabapentin	382	104
Lisinopril	Lisinopril	372	104
Duloxetine Hcl	Duloxetine Hcl	323	73
Omeprazole	Omeprazole	292	84
Metoprolol Succinate	Metoprolol Succinate	283	88
Jardiance	Empagliflozin	258	57
Pravastatin Sodium	Pravastatin Sodium	236	73
Tamsulosin Hcl	Tamsulosin Hcl	222	65
Metformin Hcl	Metformin Hcl	221	64
Sertraline Hcl	Sertraline Hcl	205	46
Metformin Hcl Er	Metformin Hcl	201	57
Pantoprazole Sodium	Pantoprazole Sodium	200	68
Potassium Chloride	Potassium Chloride	185	57
Trazodone Hcl	Trazodone Hcl	182	48
Hydrochlorothiazide	Hydrochlorothiazide	174	56
Fluticasone Propionate	Fluticasone Propionate	166	65
Carvedilol	Carvedilol	161	50
Furosemide	Furosemide	147	56
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	137	35
Montelukast Sodium	Montelukast Sodium	132	42
Allopurinol	Allopurinol	131	42
Albuterol Sulfate Hfa	Albuterol Sulfate	126	54
Chlorthalidone	Chlorthalidone	124	36
Ezetimibe	Ezetimibe	117	37
Metoprolol Tartrate	Metoprolol Tartrate	116	39
Ozempic	Semaglutide	112	19
Simvastatin	Simvastatin	106	31
Alendronate Sodium	Alendronate Sodium	105	33
Bupropion Xl	Bupropion Hcl	104	31
Atenolol	Atenolol	93	25
Finasteride	Finasteride	88	23
Spironolactone	Spironolactone	85	28
Eliquis	Apixaban	84	19
Synthroid	Levothyroxine Sodium	84	20
Pregabalin	Pregabalin	83	16
Glimepiride	Glimepiride	74	22
Esomeprazole Magnesium	Esomeprazole Magnesium	71	22
Memantine Hcl	Memantine Hcl	71	16
Zolpidem Tartrate	Zolpidem Tartrate	71	13
Donepezil Hcl	Donepezil Hcl	65	19
Methocarbamol	Methocarbamol	64	21
Clopidogrel	Clopidogrel Bisulfate	62	20
Escitalopram Oxalate	Escitalopram Oxalate	62	21
Irbesartan	Irbesartan	62	18
Famotidine	Famotidine	59	20
Buspirone Hcl	Buspirone Hcl	57	15
Meloxicam	Meloxicam	57	18
Hydralazine Hcl	Hydralazine Hcl	56	16
Alprazolam	Alprazolam	53	21
Trulicity	Dulaglutide	53	14
Celecoxib	Celecoxib	52	13
Doxazosin Mesylate	Doxazosin Mesylate	52	15
Ramipril	Ramipril	47	14
Citalopram Hbr	Citalopram Hydrobromide	46	14
Prednisone	Prednisone	44	33
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	43	15
Mounjaro	Tirzepatide	42	suppressed
Benazepril Hcl	Benazepril Hcl	41	11
Fenofibrate	Fenofibrate	41	11
Venlafaxine Hcl Er	Venlafaxine Hcl	38	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	37	11
Valsartan	Valsartan	37	14
Fluoxetine Hcl	Fluoxetine Hcl	34	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	34	suppressed
Cephalexin	Cephalexin	33	24
Clonazepam	Clonazepam	32	suppressed
Valacyclovir	Valacyclovir Hcl	30	18
Doxepin Hcl	Doxepin Hcl	29	14
Mirtazapine	Mirtazapine	29	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	29	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	28	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	27	suppressed
Ketoconazole	Ketoconazole	26	16
Lovastatin	Lovastatin	26	suppressed
Myrbetriq	Mirabegron	26	suppressed
Nebivolol Hcl	Nebivolol Hcl	25	suppressed
Nitroglycerin	Nitroglycerin	25	13
Triamcinolone Acetonide	Triamcinolone Acetonide	25	22
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	24	suppressed
Tramadol Hcl	Tramadol Hcl	24	11
Azelastine Hcl	Azelastine Hcl	23	15
Bumetanide	Bumetanide	22	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	22	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	22	suppressed
Premarin	Estrogens, Conjugated	22	suppressed
Tizanidine Hcl	Tizanidine Hcl	22	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Lansoprazole	Lansoprazole	21	suppressed
Nifedipine Er	Nifedipine	21	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	18
Fenofibrate	Fenofibrate Nanocrystallized	20	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	20	suppressed
Methylprednisolone	Methylprednisolone	19	18
Diclofenac Sodium	Diclofenac Sodium	18	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	18	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	16
Repatha Sureclick	Evolocumab	18	suppressed
Telmisartan	Telmisartan	18	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	14
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	17	suppressed
Ventolin Hfa	Albuterol Sulfate	17	11
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Naproxen	Naproxen	14	14
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Bydureon Bcise	Exenatide Microspheres	13	suppressed
Klor-Con M20	Potassium Chloride	13	suppressed
Warfarin Sodium	Warfarin Sodium	13	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	12	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Lorazepam	Lorazepam	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Galantamine Hbr	Galantamine Hbr	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error